Latest News - West Pharmaceutical
Top Corporates Hub
West Pharmaceutical
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth
20.02.2026 14:30
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap Strategy returned -5.75% net of fees compared to the Russell Midcap Growth Index’s -3.70% return. The underperformance was driven by negative stock selection in the Technology […]
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?
20.02.2026 13:00
West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook
13.02.2026 00:22
In the past week, West Pharmaceutical Services reported its 2025 results, with full-year sales rising to US$3.07 billion and net income edging up to US$493.7 million, while also issuing 2026 guidance that calls for first-quarter net sales of US$770 million to US$790 million and full-year net sales of US$3.22 billion to US$3.28 billion, including a foreign-exchange benefit. An important detail in that outlook is that organic net sales growth is expected to outpace reported growth,...
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up
12.02.2026 18:07
West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook.
West Pharmaceutical Services, Inc. Q4 2025 Earnings Call Summary
12.02.2026 17:32
Moby summary of West Pharmaceutical Services, Inc.'s Q4 2025 earnings call
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say
12.02.2026 14:30
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript
12.02.2026 14:14
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsJohn Sweeney - Vice President of Investor...
West Pharmaceutical Services (NYSE:WST) Beats Q4 Earnings Estimates, Shares Surge
12.02.2026 12:33
West Pharmaceutical Services beats Q4 earnings estimates, driven by strong high-value product sales, leading to a significant stock price increase.
West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates
12.02.2026 12:10
West Pharmaceutical (WST) delivered earnings and revenue surprises of +11.21% and +1.35%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12.02.2026 12:02
Feb 12 () - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on strong demand for its proprietary products, which include syringes and cartridges for injectable drugs. Shares of the Pennsylvania-based firm were up 3.
West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars
12.02.2026 11:11
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $805 million. The company expects the full year’s revenue to be around $3.25 billion, close to analysts’ estimates. Its non-GAAP profit of $2.04 per share was 11.5% above analysts’ consensus estimates.
West Pharmaceutical: Q4 Earnings Snapshot
12.02.2026 11:10
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share. The medical device company posted revenue of $805 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $794.3 million.
West Reports Fourth-Quarter and Full-Year 2025 Results
12.02.2026 11:00
West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025.
West Pharmaceutical Services, Inc. 2025 Q4 - Results - Earnings Call Presentation
12.02.2026 08:33
2026-02-12. The following slide deck was published by West Pharmaceutical Services, Inc.
West Pharmaceutical Servs Sees FY2026 GAAP EPS $7.79-$8.14 vs $7.74 Est
12.02.2026 07:44
West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 GAAP EPS of $7.79-$8.14 vs $7.74 analyst estimate..
West Pharmaceutical Servs Sees FY2026 Adj EPS $7.85-$8.20 vs $7.78 Est; Sees Sales $3.215B-$3.275B vs $3.254B Est
12.02.2026 07:43
West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 Adj EPS of $7.85-$8.20 vs $7.78 analyst estimate. sees sales of $3.215 billion-$3.275 billion vs $3.254 billion analyst estimate.
West Pharmaceutical Servs Q4 Adj. EPS $2.04 Beats $1.83 Estimate, Sales $805.000M Beat $794.377M Estimate
12.02.2026 07:41
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.83 by 11.35 percent. This is a 12.09 percent increase over earnings of $1.82 per share
West Pharmaceutical Services Earnings: What To Look For From WST
11.02.2026 03:08
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday before market hours. Here’s what to look for.
Countdown to West Pharmaceutical (WST) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
10.02.2026 14:15
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for West Pharmaceutical (WST), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.